Skip to main content
. 2022 Dec 12;37(1):72–78. doi: 10.1038/s41375-022-01768-x

Fig. 1. Consort diagram of patients (pts) treated according to the clinical trial AIEOP-BFM 2017 and analyzed for possible, probable and proven invasive fungal disease (IFD).

Fig. 1

*Yeast infection includes two patients with more than one yeast isolates. **Mold infection includes nine patients with more than one mold isolated. SAE severe adverse event, PcP Pneumocystis jirovecii pneumonia.